Prognostic significance of NLR kinetics in operable triple negative breast cancer.

被引：0
|
作者：
Ganta, Ranga Raman [1 ]
Nasaka, Srividya [1 ]
机构：
[1] HCG, Vijayawada, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14201
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14201
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Inhibiting fatty acid synthase in operable triple negative breast cancer.
    Sardesai, Sagar D.
    Thomas, Alexandra
    Gallagher, Christopher
    Lynce, Filipa
    Ottaviano, Yvonne Lynn
    Ballinger, Tarah Jean
    Schneider, Bryan P.
    Storniolo, Anna Maria
    Bauchle, Amber
    Althouse, Sandra K.
    Perkins, Susan
    Zhang, Jian-Ting
    Miller, Kathy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Prognostic significance of BRMS1 promoter methylation in operable breast cancer.
    Chimonidou, Maria
    Kallergi, Galatea
    Georgoulias, Vasilis
    Welch, Danny
    Lianidou, Evi
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [3] Prognostic Significance of Immunohistochemical Markers in Triple Negative Breast Cancer
    Han, Rachel
    Nofech-Mozes, Sharon
    Olkhov-Mitsel, Ekaterina
    Chehade, Rania
    Jerzak, Katarzyna J.
    Slodkowska, Elzbieta
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S140 - S141
  • [4] Prognostic significance of triple-negative phenotype in breast cancer
    Lee, K. E.
    Choi, M. Y.
    Chang, H. J.
    Sung, S. H.
    Moon, B. I.
    Choi, H. Y.
    Nam, E. M.
    Mun, Y. C.
    Seong, C. M.
    Lee, S. N.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 188 - 188
  • [5] Prognostic significance of triple-negative phenotype in breast cancer
    Choi, M. Y.
    Lee, K. E.
    Chang, H. J.
    Sung, S. H.
    Moon, B. I.
    Choi, H. Y.
    Suh, H. S.
    Nam, E. M.
    Mun, Y. C.
    Seong, C. M.
    Lee, S. N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] The prognostic impact of age in patients with triple-negative breast cancer.
    Liedtke, C.
    Gluz, D.
    Kiesel, L.
    Hortobagyi, G. N.
    Pusztai, L.
    Gonzalez-Angulo, A. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Clinical and prognostic significance of menopausal status in triple negative breast cancer
    Nakano, M.
    Fujisue, M.
    Tashima, R.
    Okumura, Y.
    Nishiyama, Y.
    Ohsako, T.
    Toyozumi, Y.
    Arima, N.
    Nishimura, R.
    [J]. BREAST, 2015, 24 : S109 - S109
  • [8] Prognostic significance of miR-16 in triple negative breast cancer
    Celik, S.
    Tuncel, T.
    Emirzeoglu, L.
    Berber, U.
    Ozgun, A.
    Bilgi, O.
    Karagoz, B.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 29 - 29
  • [9] Clinicopathological Characteristic and Prognostic Significance of Indonesian Triple Negative Breast Cancer
    Widodo, Irianiwati
    Dwianingsih, Ery Kus
    Aryandono, Teguh
    Soeripto, Soeripto
    [J]. INDONESIAN BIOMEDICAL JOURNAL, 2019, 11 (03): : 286 - 292
  • [10] Outcome of operable breast cancer with triple negative phenotype
    Izarzugaza, Y.
    Khosravi-Shahi, P.
    Soria Lovelle, A.
    Perez Manga, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345